Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.035 USD | +2.55% | +4.36% | -22.50% |
10/04 | Terns Pharmaceuticals, Inc. Appoints Melita Sun Jung as Chief Business Officer | CI |
27/03 | UBS Trims Terns Pharmaceuticals Price Target to $18 From $19, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.50% | 318M | |
+2.19% | 42.75B | |
+47.70% | 41.61B | |
+11.46% | 41.34B | |
-12.36% | 26.59B | |
+8.61% | 25.49B | |
-23.06% | 18.12B | |
+30.73% | 12.24B | |
-1.44% | 11.76B | |
+8.46% | 11B |
- Stock Market
- Equities
- TERN Stock
- News Terns Pharmaceuticals, Inc.
- Terns Pharmaceuticals' : Q2 Loss Narrows, Operating Expenses Increase; Shares Climb